The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

The Food and Drug Administration announced a recall of cucumbers grown by Bedner Growers and distributed by Fresh Start ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk, ...

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...

UW Health's Dr. Jeff Pothof discusses new requirements from the U.S. Food and Drug Administration as it relates to yearly updated to COVID-19 shots.

A new FDA framework for Covid-19 vaccines created confusion among physicians about what it means for young children ...